Originally published In Press as doi:10.1074/jbc.M112064200 on February 20, 2002
J. Biol. Chem., Vol. 277, Issue 17, 14786-14792, April 26, 2002
Control of Actin Dynamics by Proteins Made of
-Thymosin
Repeats
THE ACTOBINDIN FAMILY*,
Maud
Hertzog
,
Elena G.
Yarmola§,
Dominique
Didry
,
Michael R.
Bubb§, and
Marie-France
Carlier
¶
From the
Dynamique du Cytosquelette, Laboratoire
d'Enzymologie et Biochimie Structurales, CNRS, 91198 Gif-sur-Yvette, France and the § Division of Rheumatology,
University of Florida, Gainesville, Florida 32608-1197
Received for publication, December 18, 2001, and in revised form, February 15, 2002
 |
ABSTRACT |
Actobindin is an actin-binding protein from
amoeba, which consists of two
-thymosin repeats and has been shown
to inhibit actin polymerization by sequestering G-actin and by
stabilizing actin dimers. Here we show that actobindin has the same
biochemical properties as the Drosophila or
Caenorhabditis elegans homologous protein that consists of
three
-thymosin repeats. These proteins define a new family of
actin-binding proteins. They bind G-actin in a 1:1 complex with
thermodynamic and kinetic parameters similar to
-thymosins. Like
-thymosins, they slow down nucleotide exchange on G-actin and make a
ternary complex with G-actin and Latrunculin A. On the other hand, they
behave as functional homologs of profilin because their complex with
MgATP-G-actin, unlike
-thymosin-actin, participates in filament
barbed end growth, like profilin-actin complex. Therefore these
proteins play an active role in actin-based motility processes. In
addition, proteins of the actobindin family interact with the pointed
end of actin filaments and inhibit pointed end growth, maybe via the
interaction of the
-thymosin repeats with two terminal subunits.
 |
INTRODUCTION |
Proteins of the
-thymosin family are small (5 kDa) peptides
that act as G-actin sequestering factors, because they bind ATP-G-actin in a 1:1 complex that is unable to polymerize into filaments (1-5). In vivo, these proteins build a reservoir of unassembled
(monomeric) actin (6-8). The interaction of thymosin
4, the major
variant, and thymosin
10, a minor variant, with actin has been
thoroughly analyzed (3, 9-14). Because
-thymosins are simple
passive sequesterers in rapid equilibrium with ATP-G-actin, the balance between polymerized (F-actin) and nonassembled actin in living cells is
in fact controlled by regulatory proteins that affect the steady-state
concentration of free ATP-G-actin by modulating the dynamic parameters
of filament assembly-disassembly at the barbed and pointed ends. The
amount of sequestered actin is increased by proteins that cause an
increase in steady-state ATP-G-actin and vice versa. For instance,
profilin makes a complex with G-actin that energetically contributes to
monomer-polymer exchanges at the barbed ends as well as ATP-G-actin
itself. As a result, profilin causes a decrease in the partial critical
concentration of ATP-G-actin. Therefore, upon addition of profilin to a
solution of F-actin in the presence of T
4, the amount of T
4-actin
complex decreases, i.e. F-actin increases (15). Conversely,
addition of actin depolymerizing factor (ADF), which increases the
concentration of ATP-G-actin at steady state, leads to increased
sequestration of G-actin by T
4, i.e. causes F-actin
disassembly (16).
The structure of the T
4-actin complex is not known at atomic
resolution; however, NMR and biochemical studies consistently show that
T
4 binds actin in an extended configuration, the N-terminal segment
interacting with the barbed end of the actin monomer, while the
C-terminal region binds subdomain 2 at the pointed end of the actin
monomer (13, 14). This view satisfactorily accounts for the fact that
T
4 inhibits G-actin association with both the barbed and the pointed
ends of actin filaments.
-Thymosins have been found in all vertebrates and in echinoderms and
mollusks (17, 18). Recently, a cDNA clone encoding for a 41-amino
acid
-thymosin has been identified in the calcareus sponge
Scyon raphanus (19), indicating the ancient character of
-thymosin among metazoa. On the other hand,
-thymosins are absent
in yeast, amoeba, Drosophila, and plants. In
Acanthamoeba castellanii, a protein called actobindin
consists of two
-thymosin repeats and has been identified as a
G-actin-binding protein that may also sequester actin dimers (20-24).
A BLAST search on the complete genomic sequences of Drosophila
melanogaster and Caenorhabditis elegans identified a
triplicate
-thymosin sequence (19). Independently, this
3-
-thymosin repeat protein, called ciboulot (Cib), has been identified in Drosophila as being involved in the control of
brain development during metamorphosis and characterized as a
G-actin-binding protein (25). Amazingly, although ciboulot shares
sequence homology with T
4, the Cib-actin complex participates in
filament barbed end assembly like profilin-actin (25). The
profilin-like property of Cib accounts for its function in actin-based
motility and axonal growth. These observations raise an issue of
structural and functional relevance about the evolution of the actin
binding domain of
-thymosins. Are some biochemical properties of
-thymosins found unaltered in actobindin and Cib? What are the
structural features at the origin of the functional difference between
T
4 and Cib? Is actobindin, the amoeba
-thymosin two-repeat
protein, functionally similar to T
4 or to Cib?
Here we compare Cib and actobindin regarding their binding to G-actin,
their effects on nucleotide exchange on G-actin, and their effects on
actin assembly at the two ends of filaments, with either MgATP-actin or
CaATP-actin. We show that actobindin is functionally similar to Cib or
profilin, and differs from
-thymosins, regarding the control of
filament dynamics. On the other hand, actobindin and Cib both slow down
nucleotide exchange on G-actin like T
4. We conclude that proteins
that consist of
-thymosin repeats like actobindin in
Acanthamoeba or ciboulot in Drosophila and
probably the C. elegans homolog must play a positive role in
motile properties of living organisms. The pure G-actin sequestering function of regular
-thymosins may result from divergent evolution.
 |
MATERIALS AND METHODS |
Proteins--
Actin was purified from rabbit muscle, isolated as
CaATP-G-actin by Sephadex G 200 chromatography in G buffer (5 mM Tris-Cl, pH 7.8, 0.2 mM ATP, 1 mM dithiothreitol, 0.01% NaN3). Actin
was pyrenyl labeled on cysteine 374 (26) and
NBD1-labeled on lysine 373 (27). Gelsolin was a kind gift from Dr. Yukio Doi (University of Kyoto,
Kyoto, Japan) and actobindin was purified from
Acanthamoeba castellanii (20). Thymosin
4 and profilin
were prepared as described previously (15). The fusion protein
GST-Cib cloned in the expression vector p-GEX2T* (Amersham Bioscience) was induced in Escherichia coli strain
BL21 and purified (15). The Cib protein was then cleaved off the GST
moiety with thrombin, dialyzed against 20 mM Tris-Cl, 1 mM dithiothreitol, pH 7.5, and stored at
80 °C. The
concentration of Cib was derived from amino acid analysis, from which a
standardized bicinchoninic acid assay was developed.
Actin Polymerization Measurements--
Steady-state measurements
of F-actin were derived from fluorescence measurements of
pyrenyl-labeled actin. Actin (10% pyrenyl-labeled) was polymerized
under physiological ionic conditions (0.1 M KCl, 1 mM MgCl2) in the absence or presence of
gelsolin (at 1:300 molar ratio to actin) and in the presence or absence
of Cib or actobindin at the indicated concentrations. The value of the
equilibrium dissociation constant KC for the
Cib-actin (or actobindin-actin) complex [CA] was derived from
measurements of the amount of assembled actin at steady state (after
18-h incubation) (see the following equations),
|
(Eq. 1)
|
where [AU] and [A] are the concentrations of
unassembled actin and free G-actin at steady state and
[C0] is the total concentration of actobindin
or Cib.
Initial rates of filament growth from the barbed and the pointed ends
were measured spectrofluorometrically using either spectrin-actin seeds
(28) or gelsolin-actin seeds, respectively. Gelsolin-actin seeds were
prepared by mixing gelsolin and a 2.5 molar equivalent CaATP-G-actin in
G buffer. The adequate amount of seeds was added at time 0 together
with salt to a solution of MgATP- or CaATP-G-actin (10%
pyrenyl-labeled) and Cib or actobindin. The initial rate of pyrene
fluorescence increase was converted into molar amount of assembled
F-actin using a critical concentration plot derived from the same actin
solution. Data were analyzed and simulated as described in Yarmola
et al. (29)
Depolymerization rates at the pointed ends were measured by 20-fold
dilution of a solution of 2.5 µM gelsolin-capped
filaments (50% pyrenyl-labeled) in F buffer containing known amounts
of Cib or actobindin.
Nucleotide Exchange on G-actin--
Kinetics of nucleotide
exchange on monomeric actin were monitored using the change in
fluorescence of
ATP upon binding to G-actin (30). ATP-G-actin 1:1
complex was obtained by Dowex-1 treatment and diluted to 1 µM in 5 mM Tris-Cl, pH 7.8, 0.1 mM CaCl2, 1 mM dithiothreitol, in
the presence of Cib or actobindin. The increase in fluorescence
(
exc = 350 nm,
em = 410 nm) upon addition
of 5 µM
ATP was monitored using a Safas flx
spectrofluorometer. The fluorescence time courses were satisfactorily
analyzed in terms of a monoexponential process. The observed first
order rate constant displayed hyperbolic saturation behavior with the
concentration of Cib or actobindin, consistent with a model in which
Cib or actobindin shuttle from one molecule of G-actin to the other at a faster rate than nucleotide dissociates from G-actin or from Cib-actin or actobindin-actin complexes. The equilibrium dissociation constant for the Cib-actin or actobindin-actin complex was derived from
the dependence of the apparent exchange rate constant on the
concentration of Cib or actobindin, as follows,
|
|
|
|
|
(Eq. 2)
|
with
|
(Eq. 3)
|
|
(Eq. 4)
|
where [A], [A0],
[C], [C0] are the free and total
concentrations of G-actin and Cib or actobindin and [CA]
is the concentration of the complex;
k1 and k2 are the
rate constants for nucleotide dissociation from G-actin and from the
CA complex, respectively; KC is the
equilibrium dissociation constant of the CA complex. The
values of k1 and k2 were
determined experimentally in the absence and in the presence of
saturating amounts of Cib. The value of KC was
derived from the adjustment of the calculated curves
kobs ([C0]) to the data.
Equilibrium and Kinetic Measurements of the Interaction of Cib
with G-actin--
The change in fluorescence of NBD-labeled G-actin
was used as a probe for the formation of the complexes of G-actin with
T
4, actobindin, or Cib. Static fluorescence measurements were
carried out in a Spex Fluorolog 2 spectrofluorimeter in G buffer for
CaATP-G-actin and in G buffer supplemented with 10 µM
MgCl2 and 0.2 mM EGTA for MgATP-G-actin.
Samples contained 1.5 µM NBD-G-actin and different amounts of Cib. Excitation and emission wavelengths were 475 nm and 525 nm, respectively. The equilibrium dissociation constant for the complex
was derived from the dependence of the fluorescence change on the total
concentration of T
4, actobindin, or Cib, analyzed using Equation 4.
The kinetics of interaction of NBD-G-actin with Cib were
monitored by fluorescence (
exc = 470 nm, slit 0.25 mm)
using a stopped-flow apparatus (DX-18 MV, Applied Photophysics), with a
270-µs noise filter. A solution of
K2Cr2O7 was placed on the emission
beam to eliminate light scattered at the excitation wavelength. Four to
six superimposable time courses were averaged for each concentration of Cib.
 |
RESULTS |
Direct Binding and Kinetics of Interaction of Cib and Actobindin
with G-actin--
To evaluate the thermodynamic and rate parameters of
the interaction of Cib and of actobindin with G-actin, we sought
suitable spectroscopic probes. While binding of T
4 to G-actin is
accompanied by a 20% increase (11), and binding of profilin by a 25%
decrease (30) in tryptophane fluorescence of actin, no change was
observed with Cib. T
4 also causes a large change in the fluorescence
of AEDANS-labeled actin (14). Binding of Cib to AEDANS-G-actin caused a
7-nm blue shift in the excitation and emission spectra and a 5%
increase in fluorescence (
exc = 340 nm,
em = 480 nm), suggesting a less polar environment of the
AEDANS fluorophore in the Cib-actin complex than in G-actin (an effect
conspicuously opposite to the one observed (14) with T
4), but the
signal was too small to be useful in kinetic experiments. Like T
4,
neither actobindin nor Cib affected the fluorescence of pyrenyl-labeled G-actin, in agreement with previous reports (22, 25). On the other
hand, the fluorescence of actin in which lysine 373 was NBD-labeled was
increased by 25% upon binding of Cib, actobindin, or T
4 (Fig.
1). A similar change has been reported
when actobindin bound to actin in which cysteine 374 was labeled by
IANBD (22). The equilibrium dissociation constants
KC of the 1:1 complexes of G-actin with T
4,
Cib, and actobindin were derived from the analysis of the dependence of
the fluorescence change on protein concentration according to Equation 4 (Fig. 1). Similar values of KC were obtained
for all proteins, typically 2-4 µM for CaATP-G-actin and
0.7-2 µM for MgATP-G-actin (Table
I).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Compared binding of
T 4, Cib, and actobindin to ATP-G-actin using
NBD fluorescence, in the absence and presence of latrunculin A. The change in fluorescence F of NBD-G-actin (1.5 µM, in G buffer) was measured at the indicated
concentrations of T 4 (A), Cib (B) or
actobindin (C), in the absence (closed circles)
and in the presence (open circles) of 20 µM
latrunculin A. The fluorescence of NBD-G-actin was taken as 1 arbitrarily. It was increased to a value of 1.04 in the presence of
latrunculin A.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Compared equilibrium parameters for binding of T 4, actobindin, and
ciboulot to G-actin using different methods
Values of KC derived from the change in NBD-actin
fluorescence and from the decrease in the rate of nucleotide exchange
were obtained in low ionic strength G buffer. Values derived from
steady-state F-actin measurements were obtained in F buffer (0.1 M KCl). ND, not determined.
|
|
Latrunculin A is a drug that interacts with G-actin with high affinity
(5 µM
1) and prevents polymerization (31).
Latrunculin A has been shown to noncompetitively inhibit T
4 binding
to G-actin, decreasing the affinity of actin for T
4 by approximately
an order of magnitude in the ternary complex (32). The present data
show that in the presence of saturating (20 µM)
concentrations of latrunculin A, the change in fluorescence of
NBD-actin (1.5 µM) upon binding Cib or actobindin or
T
4 was lower. The value of KC for binding T
4 or Cib or actobindin to NBD-G-actin was increased about 2-fold by
latrunculin A (Table I). The data are consistent with the formation of
a ternary complex between G-actin, latrunculin A, and either Cib or
actobindin or T
4.
No binding of Cib or actobindin to ADP-actin was detected using the
change in NBD-fluorescence (data not shown). It is known that the
fluorescence of NBD-actin, in contrast to pyrenyl-actin, is not
affected by the bound nucleotide (33). In conclusion, like T
4 and
profilin, Cib has a high specificity for binding ATP-G-actin.
The change in NBD fluorescence was used to monitor the kinetics of
Cib-actin complex formation. Cib bound to NBD-G-actin within a single
exponential process. The apparent first order rate constant kobs increased practically linearly with Cib
concentration in the range 0-40 µM Cib (Fig.
2). The apparent association rate constant (k+ = 1.6 µM
1·s
1) was derived from
the slope, and the apparent dissociation rate constant (k
= 14 s
1) was derived from the lower limit of
kobs at low Cib concentration. The value of the
ratio k
/k+ (3 µM) was in good agreement with the equilibrium
dissociation constant derived from the dependence of the fluorescence
change on Cib concentration. The value of 14 s
1 for
k
was then confirmed by a competition
experiment in which Cib was displaced from the Cib-NBD-actin complex by
a 10-fold excess of unlabeled actin.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 2.
Kinetics of interaction of NBD-labeled actin
with Cib. A, stopped-flow fluorescence traces recorded
upon mixing 1.5 µM NBD-G-actin with Cib at the following
concentrations: 3, 10, and 38 µM
(bottom to top curves). Time is expressed in
milliseconds (ms). Noisy curves, experimental data; smooth curves,
monoexponential best fits. B, replot of the extent of
fluorescence change at different Cib concentrations. The curve is
calculated using Equation 1. C, change in
kobs versus total concentration of
Cib.
|
|
To verify that the affinity of Cib or actobindin is not affected by NBD
labeling, the following experiment was carried out. Increasing amounts
of actobindin or Cib were added to two parallel samples of actin,
containing either 10 or 50% NBD-actin, polymerized at 1.6 µM in the presence of 4 nM gelsolin. The
linear decrease in the amount of F-actin was consistent with the same
affinity of Cib or actobindin for G-actin independently of the
proportion of labeled actin (supplementary data, Fig. 1).
Actobindin and Cib Slow Down Nucleotide Exchange on
G-actin--
Thymosin
4 is known to slow down nucleotide
dissociation from G-actin, while profilin accelerates it. It has often
been proposed that the effect of profilin on nucleotide exchange
supports its effect on motility in vivo. Both actobindin and
Cib, which enhance actin-based motility like profilin in an in
vitro reconstituted motility assay (25), slow down nucleotide
dissociation from G-actin, like T
4 (Fig.
3). The exchange rate was decreased 12- and 9-fold by actobindin and by Cib, respectively, while it was decreased 20-fold by T
4 under the same conditions. Analysis of the
data using Equation 2 yielded values of 2.0 µM and 1.7 µM for the equilibrium disssociation constants for
binding of actobindin and Cib, respectively, to CaATP-G-actin in G
buffer.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3.
Actobindin and Cib slow down nucleotide
exchange on G-actin. ATP-G-actin 1:1 complex (1 µM,
in G0 buffer containing 20 µM
CaCl2) was supplemented with Cib (A) or
actobindin (B) at the indicated concentrations. The
dissociation of bound ATP was monitored by adding 5 µM
-ATP at time 0 and recording the subsequent increase in fluorescence
of -ATP. The pseudo-first order exchange rate constant is plotted
versus the total concentration of actobindin or Cib. The
curves are calculated using Equation 2 and values of 2 and 1.7 µM for the equilibrium dissociation constants for the
actobindin-actin complex and Cib-actin complex, respectively.
|
|
This result indicates that Cib and actobindin share some of the binding
features of T
4. Their association with G-actin is linked to the
slower dissociation of ATP. However, the effects of these two proteins
on the dynamics of actin filaments are independent of their effects on
nucleotide exchange on G-actin.
The Actobindin-Actin Complex Participates in Barbed End Assembly of
MgATP-actin, Like Cib-Actin and Profilin-Actin--
The effect of
actobindin on the steady-state amount of 10% pyrenyl-labeled F-actin
was measured under physiological conditions (0.1 M KCl, 1 mM MgCl2) in the absence and in the presence of gelsolin (Fig. 4). When the barbed ends
of filaments were capped, actobindin caused depolymerization of
F-actin. The amount of depolymerized actin increased linearly with the
concentration of actobindin, consistent with sequestration of
MgATP-G-actin by actobindin in a 1:1 complex, with an equilibrium
dissociation constant KC of 6 µM.
This value is in good agreement with previous measurements (22-24), as
well as with the value derived from nucleotide exchange kinetics (Fig.
3). A similar value (KC = 2.5 µM)
had been found for the Cib-actin complex using the same assay (25). In
contrast, actobindin did not depolymerize F-actin when barbed ends were free. The very slow decrease in F-actin versus actobindin
concentration is consistent with the lowering of the steady-state
concentration of G-actin upon addition of actobindin. As an example, at
20 µM actobindin, the measured concentration of
unassembled actin was 0.15 µM (Fig. 4). Using Equation 1
with [C0] = 20 µM,
[AU] = 0.15 µM, and
KC = 5 µM, the value of
CC (free G-actin) is 0.03 µM, much
lower than the value of 0.1 µM measured in the absence of actobindin. This result implies that actin-actobindin complex, like
profilin-actin complex, participates in barbed end assembly as well as
actin itself, hence it lowers the energetic contribution of G-actin to
monomer-polymer exchanges at steady state. In conclusion, actobindin-actin complex, like Cib-actin and profilin-actin, can stabilize the barbed ends, via monomer-polymer exchange reactions, as
efficiently as G-actin.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Actobindin sequesters MgATP-G-actin only when
barbed ends are capped. Actobindin was added at the indicated
concentrations to F-actin (1.6 µM, 10% pyrenyl-labeled),
assembled in the absence (open circles) and in the presence
(closed circles) of gelsolin at 1:300 molar ratio to actin.
The data obtained in the presence of gelsolin are consistent with the
formation of a nonpolymerizable actin-actobindin 1:1 complex with an
equilibrium dissociation constant KC of 5 µM. The dashed line is calculated assuming
sequestration at the barbed ends with KC = 5 µM and a steady-state concentration of ATP-G-actin of 0.1 µM. Inset, the actin-actobindin complex
productively associates with barbed ends. The rate of barbed end growth
was measured using spectrin-actin seeds (see "Materials and
Methods") and 2.5 µM pyrenyl-actin. Values of the rate
were identical at 2.5, 10, and 15 µM actobindin.
|
|
The validity of the above conclusions relies on the assumption that the
affinity of actobindin for actin is not affected by pyrenyl labeling.
This was first established by Lambooy and Korn (20). We have confirmed
this conclusion both for Cib and actobindin by checking that the value
of KC derived from assays shown in Fig. 4 was
independent of the proportion of pyrenyl-actin.
In agreement with the above data, actobindin failed to completely
inhibit barbed end growth in a seeded polymerization assay (Fig. 4,
inset). When all MgATP-G-actin was in complex with
actobindin, the rate of barbed end growth was 70% of the rate observed
with G-actin alone, indicating that the actobindin-actin complex
associates with barbed ends with a rate constant only 30% lower than
G-actin. This value is identical to the one found first for
profilin-actin (30) and Cib-actin (25) association with barbed ends.
Association of Actobindin or Cib with Filament Pointed Ends Blocks
Pointed End Growth but Not Depolymerization--
The steady-state
measurements displayed in Fig. 1 show that actobindin and Cib form a
1:1 complex with MgATP-G-actin that does not participate in pointed end
filament assembly. Formation of this complex is expected to cause
inhibition of filament pointed end elongation from G-actin subunits.
Seeded growth assays using gelsolin-actin seeds were carried out at two
different concentrations of G-actin. The decrease in the initial rate
of elongation off gelsolin-actin seeds upon addition of actobindin
should reflect saturation of G-actin by actobindin. Hence more
actobindin should be needed to saturate a higher amount of G-actin.
Typically, since the pointed end critical concentration is 0.5 µM, the rate of growth is expected to reach zero when 1.5 µM complex is formed at 2 µM actin and when
4.5 µM complex is formed at 5 µM actin. 50% inhibition of elongation should therefore be reached at an actobindin concentration A50% = 3.75 µM at 2 µM actin and A50% = 6.34 µM at 5 µM actin (using the law of
mass action with actin-actobindin complex = 1/2(total actin
0.5 µM) and KC = 5 µM). In the case of Cib, 50% inhibition of filament
growth should be achieved by addition of 2.25 µM Cib at 2 µM actin and 4.3 µM Cib at 5 µM actin. The experimental data differed from the
expected behavior. Elongation of filaments off gelsolin-actin seeds was
inhibited by actobindin and Cib, but the rate of growth at pointed ends
displayed superimposable concentration dependencies (within
experimental error) at 2 µM and at 5 µM
G-actin and could not be accounted for by the calculated curves within
a sequestration model (Fig. 5).
Half-inhibition was observed at a lower concentration of actobindin or
Cib than expected within the sequestration activity. The superimposable
curves at two different actin concentrations suggest that actobindin or
Cib bind to pointed ends with high affinity, preventing their growth.
Analysis within pointed end capping with a KP
value of 0.6 µM and a sequestration constant KC of 5 µM for actobindin and 2.5 µM for Cib satisfactorily accounted for the data (Fig.
5). The fact that a higher affinity is observed for binding to the
pointed end than for binding to monomeric actin suggests, in agreement
with previous results (23), that actobindin and Cib may interact
with two actins at the pointed end, via their T
4 repeats. Similar
data were obtained using CaATP-actin instead of MgATP-actin and a
polymerization buffer that contained 0.1 M KCl.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Actobindin and Cib inhibit pointed end
elongation by binding to the pointed ends. The rate of elongation
from the pointed ends was measured using gelsolin-actin seeds (5 nM) and either 5 µM (open symbols)
or 2 µM (closed symbols) G-actin (10%
pyrenyl-labeled), in the presence of actobindin (triangles)
or Cib (circles) at the indicated concentrations. Rates are
normalized taking the 100% reference for the rate of elongation
measured in the absence of actobindin or Cib. The curves are calculated
for actobindin, at 5 µM actin (dashed lines)
and 2 µM actin (continuous lines), using a
simple sequestration model (thin lines,
KC = 5 µM) and a combined capping
and sequestration model (thick lines,
KC = 5 µM,
KP = 0.7 µM).
|
|
To determine whether actobindin and Cib prevent pointed end
disassembly, dilution-induced depolymerization of gelsolin-capped filaments was performed. The initial rate of depolymerization from the
pointed ends was not affected by either actobindin or Cib up to 10 µM (see supplemetary data Fig. 2). In conclusion, association of actobindin or Cib with pointed ends prevents growth but
not depolymerization. The behavior of Cib and actobindin has some
similarity here with DNase I, which also prevents pointed end growth
but does not prevent depolymerization (34). The failure of Cib and
actobindin to prevent pointed end depolymerization may be in relation
with the poor binding of these proteins to ADP-actin, which is exposed
at depolymerizing pointed ends, while ATP-actin is at the end of
growing filaments. Therefore at the steady state of assembly of
gelsolin-capped filaments, the relevant reaction is essentially the
sequestration of monomeric actin by actobindin or Cib.
Actobindin and Cib Act as Purely G-actin Sequestering Proteins When
CaATP Is Bound to Actin--
Polymerization of CaATP-actin is
quasi-reversible due to the slow hydrolysis of ATP on CaATP-F-actin.
Consistently, the critical concentrations are practically identical
(0.6 µM) at the two ends. Profilin-CaATP-actin failed to
polymerize at the barbed ends (35). Both actobindin and Cib displayed
the same behavior as profilin regarding interaction with CaATP-actin
and caused depolymerization of F-actin (i.e. sequestration
of G-actin) at the barbed and at the pointed end (Fig.
6). Values of 8 ± 1 µM were derived from the data for the equilibrium
dissociation constants of the complexes of CaATP-G-actin with either
actobindin or Cib. In conclusion, the general features of the different
interactions of profilin with CaATP-actin and MgATP-actin are
displayed by actobindin and Cib.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Actobindin and Cib act as pure G-actin
sequestering proteins with CaATP-G-actin. CaATP-actin (1.6 µM, 10% pyrenyl-labeled) was polymerized in the presence
of 0.1 M KCl, in the absence (closed symbols) or
presence (open symbols) of gelsolin (5 nM), and
supplemented with actobindin (triangles) or Cib
(circles) as indicated. The steady-state amount of F-actin
was measured following 18-h incubation at room temperature.
|
|
 |
DISCUSSION |
We have shown that regarding its biochemical properties and
biological function, the amoeba protein actobindin is a member of a new
family of actin-binding proteins. These proteins consist of two or
three
-thymosin repeats and share some biochemical properties with
-thymosins. For instance they bind ATP-G-actin specifically with
thermodynamic and rate parameters very similar to T
4 and slow down
nucleotide dissociation from G-actin-like
-thymosins, indicating
that their binding sites appreciably overlap the T
4 binding site on
G-actin. This conclusion is in agreement with results from
EDC-cross-linking experiments, which indicated that lysine 18 of
T
4 (13) and lysine 16 of actobindin (36) make contacts with the 4 N-terminal acidic residues of actin. The rate constant for association
to G-actin is lower than the expected diffusion-limited rate constant,
suggesting, as proposed for T
4 (14), that the formation of a low
affinity rapid equilibrium collision complex is followed by a
reversible isomerization step leading to a tighter interaction;
alternatively, the protein might be in rapid equilibrium between
several conformational states, one of which only binds G-actin.
On the other hand, unlike
-thymosins, these proteins are not pure
G-actin sequesterers but actually regulate the dynamics of filament
assembly using the same mechanism as profilin, i.e. their
complex with MgATP-G-actin participates in barbed end growth exclusively. This property is observed in kinetic assays of seeded filament growth. Its consequence at steady state is the lowering of the
steady-state concentration of free G-actin, consistent with
copolymerization of actin and actobindin-actin or Cib-actin complexes.
The failure of actobindin to depolymerize actin at steady state when
barbed ends are free or inhibit barbed end growth had been noticed
previously but had been explained differently (24). Due to the ability
of their complex with actin to participate in barbed end growth,
proteins of the actobindin family play an active role, like profilin,
in actin-based motility processes. We have shown that the
Drosophila homolog, ciboulot, is required for axonal growth
during central brain development in metamorphosis of the fly and that
either Cib or actobindin can replace profilin in a reconstituted
motility assay (25). The present work indicates that actobindin
likewise must be required for some motile processes of the amoeba. Like
for profilin, the participation of actobindin-actin or Cib-actin to
barbed end growth is observed with MgATP-actin only, and a pure G-actin
sequestering function is observed with CaATP-actin. These results point
to a possible role of ATP hydrolysis associated with actin
polymerization in this function. Actobindin consists of two imperfect
-thymosin repeats, while the Drosophila and C. elegans proteins harbor three
-thymosin repeats, suggesting that their functional difference with T
4 might correlate with the
fact that the
-thymosin motif is repeated. This view is not supported, however, by the following observations. Similar G-actin binding motifs showing similarity with T
4, called "verprolin homology region" or WH2 domain, are found in WASp family proteins, and in the ActA protein of Listeria, where they have been
demonstrated to share the same functional homology with profilin (Refs.
37-39 and see Ref. 40 for a recent review). In these proteins, the G-actin binding module is generally not repeated, except in the case of
N-WASp (the neural form of WASp), which contains a tandem of two
verprolin homology regions. Hence it seems likely that a subtle
difference in sequence in the G-actin binding motif, rather than the
repeat of the motif, is responsible for the functional difference
between
-thymosins and these proteins. The repeated sequences would
then simply help to enhance the affinity of these proteins for G-actin.
Further studies of the biochemical properties of the isolated repeats
are required to challenge this view. A mutagenetic analysis of these
proteins should also help to elucidate the structural basis for the
change in function of the
-thymosin motif. In this respect, previous
studies have shown that changing the sequence
17LKKTET22 in the actin binding motif of T
4
into LKETET caused T
4-induced actin aggregation in low ionic
strength buffer (9). In addition to this segment, T
4
interacts with G-actin via helix 1 (residues 5-16) and helix 2 (residues 31-39) (42). According to Safer and co-workers (13, 14),
C-terminal helix 2 interacts with subdomain 2 at the pointed end of
G-actin. This contact may prevent association of the T
4-actin
complex to the barbed end of an actin filament. In binding to G-actin,
Cib and actobindin do not sterically interfere with subdomain 2 association to a barbed end.
Finally,
-thymosin repeat proteins display the original property,
not shown by either profilin or
-thymosins, to prevent pointed end
growth by a capping effect. This result has no physiological significance since in vivo pointed ends only depolymerize,
but it is interesting from a structural point of view. The affinity for
pointed ends is about 5-fold higher than for monomeric actin. This
result is surprising and paradoxical. Actually, the view that
actobindin-actin and Cib-actin participate in barbed end growth
intuitively suggests that these proteins are transiently bound to the
terminal subunit at the barbed end of the filament, but cannot be bound
to the pointed end. To accommodate the unexpected pointed end capping
we propose that two
-thymosin repeats of a single protein may
interact with two terminal subunits at the pointed end. The structure
of actobindin or Cib bound to the pointed end may be similar to the
structure of the reported high affinity complex of actobindin with
covalently cross-linked actin dimers obtained by reacting F-actin with
para-phenylene-bis-maleimide (43). The covalent bond
connects lysine 191 to cysteine 374 of a laterally adjacent subunit
along the genetic helix (41), i.e. may reconstitute
the pointed end structure of a filament. Resolution of the
three-dimensional structure of the complex of actobindin or Cib with
G-actin is required to challenge this hypothesis.
 |
FOOTNOTES |
*
This work was supported in part by the Ligue Nationale
contre le Cancer (to M.-F. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org) contains supplementary Figs. 1 and 2.
¶
To whom correspondence should be addressed. Tel.:
33-1-69-82-34-65; Fax: 33-1-69-82-31-29; E-mail:
carlier@lebs.cnrs-gif.fr.
Published, JBC Papers in Press, February 20, 2002, DOI 10.1074/jbc.M112064200
 |
ABBREVIATIONS |
The abbreviations used are:
NBD, 12-(N-methyl-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl));
AEDANS, 1,5-I-AEDANS,
5-[2-(iodoacetamido)ethylamino]naphthalene-1-sulfonic
acid;
IANBD, N-((2-iodoacetoxy)ethyl)N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole.
 |
REFERENCES |
| 1.
|
Safer, D.,
Elzinga, M.,
and Nachmias, V. T.
(1991)
J. Biol. Chem.
266,
4029-4032[Abstract/Free Full Text]
|
| 2.
|
Safer, D.,
and Nachmias, V. T.
(1994)
Bioessays
16,
473-479[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Weber, A.,
Nachmias, V. T.,
Pennise, C. R.,
Pring, M.,
and Safer, D.
(1992)
Biochemistry
31,
6179-6185[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Cassimeris, L.,
Safer, D.,
Nachmias, V. T.,
and Zigmond, S. H.
(1992)
J. Cell Biol.
119,
1261-1270[Abstract/Free Full Text]
|
| 5.
|
Carlier, M.-F.,
Jean, C.,
Rieger, K. J.,
Lenfant, M.,
and Pantaloni, D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5034-5038[Abstract/Free Full Text]
|
| 6.
|
Nachmias, V. T.
(1993)
Curr. Opin. Cell Biol.
5,
56-62[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Sanger, J. M.,
Golla, R.,
Safer, D.,
Choi, J. K., Yu, K. R.,
Sanger, J. W.,
and Nachmias, V. T.
(1995)
Cell Motil. Cytoskeleton
31,
305-322
|
| 8.
|
Malinda, K. M.,
Goldstein, A. L.,
and Kleinman, H. K.
(1997)
FASEB J.
11,
474-481[Abstract]
|
| 9.
|
Vancompernolle, K.,
Goethals, M.,
Huet, C.,
Louvard, D.,
and Vandekerckhove, J.
(1992)
EMBO J.
11,
4739-4746[Medline]
[Order article via Infotrieve]
|
| 10.
|
Yu, F.-X.,
Lin, S. C.,
Morrison-Bogorad, M.,
Atkinson, M. A.,
and Yin, Y. L.
(1993)
J. Biol. Chem.
268,
502-509[Abstract/Free Full Text]
|
| 11.
|
Jean, C.,
Rieger, K.,
Blanchoin, L.,
Carlier, M.-F.,
Lenfant, M.,
and Pantaloni, D.
(1994)
J. Muscle Res. Cell Motil.
15,
278-286[Medline]
[Order article via Infotrieve]
|
| 12.
|
Huff, T.,
Zerzawy, D.,
and Hannapel, E.
(1995)
Eur. J. Biochem.
230,
650-657[Medline]
[Order article via Infotrieve]
|
| 13.
|
Safer, D.,
Sosnick, T. R.,
and Elzinga, M.
(1997)
Biochemistry
36,
5806-5816[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
De La Cruz, E., M.,
Ostap, E. M.,
Brundage, R. A.,
Reddy, K. S.,
Sweeney, H. L.,
and Safer, D.
(2000)
Biophys. J.
78,
2516-2527[Abstract/Free Full Text]
|
| 15.
|
Pantaloni, D.,
and Carlier, M.-F.
(1993)
Cell
75,
1007-1014[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Didry, D.,
Carlier, M.-F.,
and Pantaloni, D.
(1998)
J. Biol. Chem.
273,
25602-25611[Abstract/Free Full Text]
|
| 17.
|
Stoeva, S.,
Horger, S.,
and Voelter, W.
(1997)
J. Pept. Sci.
3,
282-290[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Safer, D.,
and Chowrashi, P. K.
(1997)
Cell Motil. Cytoskeleton
38,
163-171[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Manuel, M.,
Kruse, M.,
Müller, W. E. G.,
and Le Parco, Y.
(2000)
J. Mol. Evol.
51,
378-381[Medline]
[Order article via Infotrieve]
|
| 20.
|
Lambooy, P. K.,
and Korn, E. D.
(1986)
J. Biol. Chem.
261,
17150-17155[Abstract/Free Full Text]
|
| 21.
|
Vandekerckhove, J.,
Van Damme, J.,
Vankompernolle, K.,
Bubb, M. R.,
Lambooy, P. K.,
and Korn, E. D.
(1990)
J. Biol. Chem.
265,
12801-12805[Abstract/Free Full Text]
|
| 22.
|
Bubb, M. R.,
Lewis, M. S.,
and Korn, E. D.
(1991)
J. Biol. Chem.
266,
3820-3826[Abstract/Free Full Text]
|
| 23.
|
Bubb, M. R.,
Knutson, J. R.,
Porter, D. K.,
and Korn, E. D.
(1994)
J. Biol. Chem.
269,
25592-25597[Abstract/Free Full Text]
|
| 24.
|
Bubb, M. R.,
and Korn, E. D.
(1995)
Biochemistry
34,
3921-3926[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Boquet, I.,
Boujemaa, R.,
Carlier, M.-F.,
and Préat, T.
(2000)
Cell
102,
797-808[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Kouyama, T.,
and Mihashi, K.
(1981)
Eur. J. Biochem.
114,
33-38[Medline]
[Order article via Infotrieve]
|
| 27.
|
Detmers, P.,
Weber, A.,
Elzinga, M.,
and Stephens, R. E.
(1981)
J. Biol. Chem.
256,
99-105[Abstract/Free Full Text]
|
| 28.
|
Casella, J. F.,
Maack, D. J.,
and Lin, S. L.
(1986)
J. Biol. Chem.
261,
10915-10921[Abstract/Free Full Text]
|
| 29.
|
Yarmola, E. G.,
Parikh, S.,
and Bubb, M. R.
(2001)
J. Biol. Chem.
276,
45555-45563[Abstract/Free Full Text]
|
| 30.
|
Perelroizen, I.,
Carlier, M.-F.,
and Pantaloni, D.
(1995)
J. Biol. Chem.
270,
1501-1508[Abstract/Free Full Text]
|
| 31.
|
Coue, M,
Brenner, SL,
Spector, I,
and Korn, ED
(1987)
FEBS Lett.
213,
316-318[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Yarmola, EG,
Somasundaram, T,
Boring, TA,
Spector, I,
and Bubb, MR
(2000)
J. Biol. Chem.
275,
28120-28127[Abstract/Free Full Text]
|
| 33.
|
Carlier, M.-F.,
Pantaloni, D.,
and Korn, E. D.
(1985)
J. Biol. Chem.
260,
6565-6572[Abstract/Free Full Text]
|
| 34.
|
Weber, A.,
Pennise, C. R.,
and Pring, M.
(1994)
Biochemistry
33,
4780-4786[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Perelroizen, I.,
Didry, D.,
Christensen, H.,
Chua, N.-H.,
and Carlier, M.-F.
(1996)
J. Biol. Chem.
271,
12302-12309[Abstract/Free Full Text]
|
| 36.
|
Vancompernolle, K.,
Vandekerckhove, J.,
Bubb, M. R.,
and Korn, E. D.
(1991)
J. Biol. Chem.
266,
15427-15431[Abstract/Free Full Text]
|
| 37.
|
Egile, C.,
Loisel, T. P.,
Laurent, V., Li, R.,
Pantaloni, D.,
Sansonetti, P. J.,
and Carlier, M. F.
(1999)
J. Cell Biol.
146,
1319-1332[Abstract/Free Full Text]
|
| 38.
|
Higgs, H. N.,
and Pollard, T. D.
(1999)
J. Biol. Chem.
274,
32531-32534[Free Full Text]
|
| 39.
|
Boujemaa, R.,
Gouin, E.,
Hansen, G.,
Samarin, S.,
LeClainche, C.,
Didry, D.,
Kocks, C.,
Cossart, P.,
Dehoux, P.,
Carlier, M.-F.,
and Pantaloni, D.
(2001)
Biochemistry
40,
11390-11404[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Paunola, E.,
Mattila, P. K.,
and Lappalainen, P.
(2001)
FEBS Lett.
25626,
1-6
|
| 41.
|
Elzinga, M.,
and Phelan, J. J.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
6599-6602[Abstract/Free Full Text]
|
| 42.
|
Simenel, C.,
Van Troys, M.,
Vandekerckhove, J.,
Ampe, C.,
and Delepierre, M.
(2000)
Eur. J. Biochem.
267,
3530-3538[Medline]
[Order article via Infotrieve]
|
| 43.
|
Bubb, M. R.,
Lewis, M. S.,
and Korn, E. D.
(1994)
J. Biol. Chem.
269,
25587-25591[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Le Clainche and M.-F. Carlier
Regulation of Actin Assembly Associated With Protrusion and Adhesion in Cell Migration
Physiol Rev,
April 1, 2008;
88(2):
489 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-F. Carlier and D. Pantaloni
Control of Actin Assembly Dynamics in Cell Motility
J. Biol. Chem.,
August 10, 2007;
282(32):
23005 - 23009.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. V. Dedova, O. P. Nikolaeva, D. Safer, E. M. De La Cruz, and C. G. dos Remedios
Thymosin {beta}4 Induces a Conformational Change in Actin Monomers
Biophys. J.,
February 1, 2006;
90(3):
985 - 992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chereau, F. Kerff, P. Graceffa, Z. Grabarek, K. Langsetmo, and R. Dominguez
|